3D Tissue Models

Cancer Biology: Thomas Jefferson University

Total Score People Score Events Score
23 20 17
Date Event Presentation Speakers
May 3, 2012 Thrombosis and Hemostasis Summit of North America (THSNA) Inpatient Transition of New Anticoagulants Geno Merli
April 15, 2012 28th IABCR/Breakthrough Breast Cancer Conference Mouse models of breast cancer Michael Lisanti
November 18, 2011 16th Annual Perspectives In Thoracic Oncology Novel approaches to radiation therapy in the palliative settings Maria Werner-Wasik
August 31, 2011 Strategies for Engineered Negligible Senescence, 5th Conference (SENS5) The true nature of the Warburg effect Michael Lisanti
August 10, 2010 The International Quantitative Imaging Cytometry Centers of Excellence Provide a Forum for Educational and Training Programs in Quantitative Imaging Cytometry, with a Specific Focus on Solid-Phase Laser Scanning Imaging Cytometry Combinatorial Development of Biomaterials for Tissue Engineering and Drug Delivery Daniel G Anderson
December 11, 2009 Santa Fe Gastrointestinal Cancer Conference Management of Pancreatic Cancer Edith P. Mitchell
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety In Vitro and In Vivo Models to Predict Cardiotoxicity: Where do we Stand? Thomas Force
Continental Breakfast Breakout Discussions Table Seven: In Vitro and In Vivo Models to Predict Cardiotoxicity Thomas Force
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting Molecular Genetics of PXE Jouni Uitto
Fibulin in Diseases Mon-Li Chu
President’s Welcome and Founder’s Award Presentation to Paul Bornstein(Randle ABC) Renato V. Iozzo
Concurrent B: Decorin binds to and downregulates the MET receptor Silvia Goldoni,
A central role for decorin during vertebrate convergent extension Jason J Zoeller
Concurrent I: Heparan sulfate function in limb synovial joint formation Maurizio , Pacifici
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Ribosome Recycling Step; The Essential Fourth Step of Protein Synthesis as a Possible Target of Antibiotics and Anti-tumor Agent : Track 1-1 Hideko Kaji
August 13, 2008 Advances In Cancer Vaccines Cancer Mucosa Antigens as Novel Immunological Targets for Tumor Therapy Adam E Snook
May 30, 2008 ASCO Annual'08 Meeting head and neck cancer-- Integrating Intensity- Modulated Radiation Therapy/Image-Guided Radiation Therapy and Systemic Therapy into a Combined Modality Therapeutic Strategy (M09) Mitchell Machtay
meet the professor sessions-- Integrating Intensity- Modulated Radiation Therapy/Image-Guided Radiation Therapy and Systemic Therapy into a Combined Modality Therapeutic Strategy (M09) Mitchell Machtay
February 11, 2008 Stem Cells World Congress The Dopamine Specification of Human Embryonic Stem Cells in Culture and after Transplantation into a Parkinson’s Disease Model Lorraine Iacovitti
February 10, 2008 GRC - Prolactin & Growth Hormone Family Opening Remarks Hallgeir Rui
Discussion Hallgeir Rui
Caveolins, PRL and GH signaling Michael Lisanti
January 18, 2008 Translational Research Program Stem Cell Symposium Brief Overview of TRP -Welcome Adam P Dicker
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Hwyda Arafat
Session 7: Antihypertensives as Novel Antineoplastics: The Use of Angiotensin Blockade Therapies in Pancreatic Ductal Adenocarcinoma (11:40-12:00) Hwyda Arafat
October 16, 2007 Inaugural Kinbase Inhibitors: Moving Forward into Clinical Studies Oct (16-17) The Challenge of Resistance and safety: Kinase Inhibitors and the Issue of Cardiac Toxicity (11:10-11:40) Thomas Force
The Challenge of Resistance and safety (10:40-12:10) Thomas Force
June 22, 2007 CNRS - Conférences du Vivant “Arf Family GTPases� Arf6 modulation of the SDF-CXCR4 axis in metastatic breast cancer cells Catherine Moore
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.